Spero Therapeutics, Inc. Contracts & Agreements

86 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sublease, dated July 6, 2016, by and between the Registrant and Tetraphase Pharmaceuticals, Inc. with respect to 480 Arsenal Street
Lease Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Interim Period Agreement, dated January 10, 2025, between the Company and Ms. Rajavelu
Spero Therapeutics, Inc.
Biotechnology
2025
Interim Period Agreement, dated January 10, 2025, between the Company and Mr. Shukla
Spero Therapeutics, Inc.
Biotechnology
2025
Amendment 4 to Exclusive License Agreement, dated October 28, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
2024
Consulting Agreement, effective as of August 5, 2024, by and between the Registrant and John C. Pottage, Jr., M.D
Consulting Agreements
Spero Therapeutics, Inc.
2024
Separation Agreement, dated July 30, 2024, by and between the Registrant and Kama Hamed
Separation Agreements
Spero Therapeutics, Inc.
2024
Consulting Agreement, effective as of August 29, 2024, by and between the Registrant and Kamal Hamed
Consulting Agreements
Spero Therapeutics, Inc.
2024
Employment Agreement, dated October 31, 2023, by and between the Registrant and Esther Rajavelu
Spero Therapeutics, Inc.
2024
Amendment 3 to Exclusive License Agreement, dated March 4, 2024, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
Spero Therapeutics, Inc.
2024
2019 Inducement Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2024
Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Spero Therapeutics, Inc.
2024
Separation Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph
Separation Agreements
Spero Therapeutics, Inc.
2024
Consulting Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph
Consulting Agreements
Spero Therapeutics, Inc.
2024
Amendment 1 to Exclusive License Agreement, dated July 4, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
2024
Amendment 2 to Exclusive License Agreement, dated December 20, 2023, by and between the Registrant and GlaxoSmithKline Intellectual Property (No. 3) Limited
License Agreements
Spero Therapeutics, Inc.
2024
Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2023
Consulting Agreement, dated June 12, 2023, by and between the Registrant and Danforth Advisors, LLC
Consulting Agreements
Spero Therapeutics, Inc.
2023
Amended and Restated Employment Agreement, dated June 13, 2023, by and between the Registrant and Satyavrat Shukla
Employment Agreements
Spero Therapeutics, Inc.
2023
Consulting Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D
Consulting Agreements
Spero Therapeutics, Inc.
2023
Transition and Separation Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D
Separation Agreements
Spero Therapeutics, Inc.
2023
Second Amendment to Employment Agreement, dated as of February 1, 2023, by and between the Registrant and Timothy Keutzer
Employment Agreements
Spero Therapeutics, Inc.
2023
Amendment 1 to Consulting Agreement, dated August 4, 2022, by and between the Registrant and Cristina Larkin
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
2022
Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2022
Separation Agreement, dated May 3, 2022, by and between the Registrant and Cristina Larkin
Separation Agreements
Spero Therapeutics, Inc.
2022
Separation Agreement, dated May 3, 2022, by and between the Registrant and David Melnick, M.D
Separation Agreements
Spero Therapeutics, Inc.
2022
Consulting Agreement, dated May 3, 2022, by and between the Registrant and Cristina Larkin
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2022
Consulting Agreement, dated May 3, 2022, by and between the Registrant and David Melnick, M.D
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2022
Revenue Interest Termination Agreement, dated June 7, 2022, by and between Spero Therapeutics, Inc., entities managed by HealthCare Royalty Management, LLC and HCR Collateral...
Termination Agreements
Spero Therapeutics, Inc.
Biotechnology
2022
Description of Registrants Securities
Spero Therapeutics, Inc.
2022
Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Spero Therapeutics, Inc.
Biotechnology
2022
Revenue Interest Financing Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and entities managed by HealthCare Royalty Management, LLC
Management Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2021
Security Agreement, dated September 29, 2021, by and between Spero Therapeutics, Inc. and HCR Collateral Management, LLC
Security Agreements
Spero Therapeutics, Inc.
2021
Form of Restricted Stock Unit Agreement under the 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2021
Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2021
License Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc
License Agreements
Spero Therapeutics, Inc.
2021
Share Purchase Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc
Share Agreements
Spero Therapeutics, Inc.
Biotechnology
DE
2021
Employment Agreement, dated December 9, 2020, by and between the Registrant and Satyavrat Shukla
Employment Agreements
Spero Therapeutics, Inc.
2021
Amended and Restated License Agreement, dated January 15, 2021, by and between the Registrant and Everest Medicines II Limited
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2021
Employment Agreement, dated November 6, 2020, by and between the Registrant and Tamara Joseph
Employment Agreements
Spero Therapeutics, Inc.
2021
Controlled Equity Offering Sales Agreement, dated March 11, 2021, by and between the Registrant and Cantor Fitzgerald & Co
Sales Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated September 10, 2020, between Spero Therapeutics, Inc. and Cowen and Company, LLC and Evercore Group, L.L.C., as representatives of the several...
Underwriting Agreements
Spero Therapeutics, Inc.
2020
Third Amendment to Lease Agreement, dated May 4, 2020, by and between the Registrant and U.S. REIF Central Plaza Massachusetts, LLC
Lease Agreements
Spero Therapeutics, Inc.
Biotechnology
2020
Amended and Restated Employment Agreement, dated April 22, 2020, by and between the Registrant and Thomas Parr Jr., Ph.D
Employment Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2020
Form of Stock Option Agreement under the 2019 Inducement Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2020
2019 Inducement Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2020
Consulting Agreement, dated November 4, 2019, by and between the Registrant and Danforth Advisors, LLC
Consulting Agreements
Spero Therapeutics, Inc.
2020
Consulting Agreement, dated April 18, 2019, by and between the Registrant and David P. Southwell
Consulting Agreements
Spero Therapeutics, Inc.
2020
Employment Agreement, dated January 1, 2020, by and between the Registrant and Timothy Keutzer
Employment Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2020
Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Spero Therapeutics, Inc.
Biotechnology
2020
Description of Registrants Securities
Spero Therapeutics, Inc.
2020
Investment Agreement, dated January 30, 2020
Investment Agreements
Spero Therapeutics, Inc.
Biotechnology
DE
2020
Securities Purchase Agreement, dated as of June 12, 2019, by and between Spero Therapeutics, Inc. and Novo Holdings A/S
Purchase Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of June 12, 2019, by and between Spero Therapeutics, Inc. and Novo Holdings A/S
Purchase Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2019
Form of Stock Option Agreement under the 2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2019
2019 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2019
License Agreement, dated January 4, 2019, by and between New Pharma License Holdings Limited and Everest Medicines II Limited
License Agreements
Spero Therapeutics, Inc.
2019
Exchange Agreement by and among Spero Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and MSI...
Exchange Agreements
Spero Therapeutics, Inc.
2018
Form of Underwriting Agreement
Underwriting Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2018
Form of Underwriting Agreement
Underwriting Agreements
Spero Therapeutics, Inc.
2018
Employment Agreement, dated December 13, 2017, by and between the Registrant and David Melnick, M.D
Employment Agreements
Spero Therapeutics, Inc.
2018
Form of Stock Option Agreement under the Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2017
Spero Therapeutics, Inc. 2017 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2017
2017 Stock Incentive Plan, as amended (to become effective upon completion of this offering)
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2017
Form of Underwriting Agreement
Underwriting Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
Employment Agreement, dated October 20, 2017, by and between the Registrant and Ankit Mahadevia, M.D
Employment Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Employment Agreement, dated October 20, 2017, by and between the Registrant and Joel Sendek
Employment Agreements
Spero Therapeutics, Inc.
2017
Employment Agreement, dated October 20, 2017, by and between the Registrant and Thomas Parr Jr., Ph.D
Employment Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Employment Agreement, dated October 20, 2017, by and between the Registrant and Cristina Larkin
Employment Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Assignment and License Agreement, dated May 9, 2016, by and among Spero Trinem, Inc., the Registrant and Vertex Pharmaceuticals Incorporated
License Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Amended and Restated License Agreement, dated June 28, 2017, by and between Spero Potentiator, Inc. and Northern Antibiotics Oy (Ltd.)
License Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
Form of Proprietary Information and Inventions Assignment Agreement
Assignment Agreements
Spero Therapeutics, Inc.
2017
Form of Stock Option Agreement under 2017 Stock Incentive Plan, as amended (to become effective upon completion of this offering)
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Non-Employee Director Compensation Policy
Compensation Agreements
Spero Therapeutics, Inc.
Biotechnology
2017
Investors Rights Agreement, dated as of June 30, 2017, by and between the Registrant and the other parties thereto
Investor Rights Agreements
Spero Therapeutics, Inc.
2017
Form of Common Stock Certificate
Stock Agreements
Spero Therapeutics, Inc.
2017
Amended and Restated License Agreement, dated June 28, 2017, by and between Spero Potentiator, Inc. and Northern Antibiotics Oy (Ltd.)
License Agreements
Spero Therapeutics, Inc.
Biotechnology
NY
2017
License Agreement, dated June 14, 2017, by and between the Registrant and Meiji Seika Pharma Co., Ltd., as supplemented by Addendum to License Agreement, dated June 14, 2017
License Agreements
Spero Therapeutics, Inc.
2017
Assignment and License Agreement, dated May 9, 2016, by and among Spero Trinem, Inc., the Registrant and Vertex Pharmaceuticals Incorporated
License Agreements
Spero Therapeutics, Inc.
2017
Stock Purchase Agreement, dated June 6, 2016, by and among Spero Cantab, Inc., the Registrant, Spero Cantab UK Limited, PBB Distributions Limited, New Pharma License Holdings...
Stock Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Lease Agreement, dated August 24, 2015, by and between the Registrant and U.S. REIF Central Plaza Massachusetts, LLC with respect to 675 Massachusetts Avenue
Lease Agreements
Spero Therapeutics, Inc.
2017
Termination and Release, dated April 14, 2017, by and between the Registrant and John Tomayko, M.D
Termination Agreements
Spero Therapeutics, Inc.
Biotechnology
2017
Letter Agreement, dated June 24, 2015, by and between the Registrant and John Tomayko, M.D
Spero Therapeutics, Inc.
2017
Form of Director and Officer Indemnification Agreement
Indemnification Agreements
Spero Therapeutics, Inc.
2017
Form of Restricted Stock Agreement under 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
Form of Stock Option Agreement under 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2017
2017 Stock Incentive Plan
Bonus & Incentive Agreements
Spero Therapeutics, Inc.
2017